December 2023 – QUAD LGBTQ+ Collaborative Meeting: Doxycycline for STI PEP

Posted on by LISHP

Title: The Pill-ars of STI Defense: Doxycycline as Post-Exposure Prophylaxis

Time/Location:
Tuesday, December 12th, 2023 at 7:00 PM
Zoom – Virtual

Speaker:
W. Justin Moore, PharmD, BCPS, BCIDP
Practice Coordinator, Antimicrobial & Diagnostic Stewardship
Clinical Pharmacist, Infectious Diseases
Northwestern Medicine
Chicago, IL

Educational Objectives:

  1. Describe the evidence for using doxycycline post-exposure prophylaxis (PEP) in the prevention of sexually transmitted infections
  2. Identify scenarios and populations where doxycycline PRP is indicated based on risk factors
  3. Review appropriate dosing/duration, and potential side effects of doxycycline PEP, while considering patient-specific factors and comorbidities
  4. Develop counseling and communication skills to effectively educate patients and clinicians on the optimal use of doxycycline PRP to prevent STI while mitigating risks of resistance